Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 2007;66(Supplement 3 ):iii45-iii48; doi:10.1136/ard.2007.079830
Copyright © 2007 BMJ Publishing Group Ltd & European League Against Rheumatism.

ANIMAL MODELS

Amplifying elements of arthritis and joint destruction

Wim B van den Berg, Peter L van Lent, Leo A B Joosten, Shahla Abdollahi-Roodsaz, Marije I Koenders

Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

Correspondence to:
Wim B van den Berg, Rheumatology Research and Advanced Therapeutics, Radboud University Nijmegen Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, The Netherlands; w.vandenberg{at}reuma.umcn.nl

Rheumatoid arthritis (RA) is a systemic autoimmune disease characterised by chronic joint inflammation and variable degrees of bone and cartilage erosion. Studies in animal models of arthritis provide insight into elements which can amplify destructive features. The presence of immune complexes in the joint makes arthritis more erosive. Although considerable bone erosion still occurs in the absence of Fc{gamma}R triggering by immune complexes, through cytokine-induced RANKL and direct osteoclast activation, cartilage erosion is heavily dependent on the Fc{gamma}R pathway. T cell factors such as IFN{gamma} and IL17 further amplify erosion through upregulation of the damaging Fc{gamma}RI and stimulation of the influx of granulocytes, respectively. Apart from immune elements, environmental pressure and components of tissue damage contribute through innate pathways. Spontaneous T cell-dependent arthritis in IL1Ra–/– mice is absent under germ-free conditions, and markedly suppressed in TLR4-deficient mice. Moreover, TLR4 blocking with a receptor antagonist suppresses erosive arthritis.

Abbreviations: CCP, citrullinated protein; Fc{gamma}R, Fc{gamma} receptors; GPI, glucose phosphate isomerase; IC, immune complex; MMPs, matrix metalloproteinases; OPG, osteoprotegerin; RA, rheumatoid arthritis; TLR, toll-like receptor; TNFtg, TNF transgenic


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • O'Neill, L. A. J., Bryant, C. E., Doyle, S. L. (2009). Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer. Pharmacol. Rev. 61: 177-197 [Abstract] [Full Text]  
  • Halvorsen, E H, Haavardsholm, E A, Pollmann, S, Boonen, A, van der Heijde, D, Kvien, T K, Molberg, O (2009). Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-{alpha} blocking agents. Ann Rheum Dis 68: 249-252 [Abstract] [Full Text]  
  • Dhodapkar, K. M., Barbuto, S., Matthews, P., Kukreja, A., Mazumder, A., Vesole, D., Jagannath, S., Dhodapkar, M. V. (2008). Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma. Blood 112: 2878-2885 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs